Cerenome (CNSY) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 172.72% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 53.21% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 47.11% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 75.60% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | -100.75% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 149.49% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -104.22% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 91.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.41% |
| Mar 31, 2026 | -158.58% |
| Dec 31, 2025 | -297.21% |
| Sep 30, 2025 | 399.70% |
| Jun 30, 2025 | -479.61% |
| Mar 31, 2025 | 273.20% |
| Dec 31, 2024 | 53.22% |
| Sep 30, 2024 | -3,423.42% |
| Jun 30, 2024 | 210.01% |
| Mar 31, 2024 | -4.74% |
| Dec 31, 2023 | -14.26% |
| Sep 30, 2023 | -94.90% |
| Jun 30, 2023 | 41.95% |
| Mar 31, 2023 | -290.10% |
| Dec 31, 2022 | 25.49% |
| Sep 30, 2022 | -47.17% |
| Jun 30, 2022 | -216.03% |
| Mar 31, 2022 | -53.47% |
| Dec 31, 2021 | -500.00% |
| Sep 30, 2021 | 351.16% |